As artificial intelligence systems rapidly outgrow traditional academic benchmarks, researchers have unveiled an ambitious new test designed to probe the true limits of machine intelligence.
Researchers debut "Humanity’s Last Exam," a benchmark of 2,500 expert-level questions that current AI models are failing.
Use Windows Sandbox to safely install and test unknown apps in an isolated environment. Protect your PC from malware and ...
Let's start with CSL's leadership change, because it sets the tone. Paul McKenzie has stepped down as chief executive, and the board has appointed long-time CSL executive and current director Gordon ...
CSL Limited (CSL.AX) reported a significant 81% decline in net profit after tax for the first half of fiscal year 2026 due to one-off costs. The company’s revenue fell 4% to $8.3 billion, while gross ...
CSL's underlying earnings fell in the first half, but management stuck to its full-year guidance and boosted the buy-back. The CSL Ltd (ASX: CSL) share price is in focus today after reporting ...
Australian pharmaceuticals heavyweight CSL has announced its chief executive Dr Paul McKenzie is retiring with immediate effect, as the company tries to rebuild confidence among investors following a ...
With pressure piling on for CSL, the Australian vaccine and plasma specialist has elected to part ways with its CEO on the eve of its latest earnings announcement. Paul McKenzie, Ph.D., who’s served ...
CSL taps ex-vaccine division head Gordon Naylor as interim CEO Appointment of Naylor is a salvage mission, says analyst CSL shares close 5% lower; co to report HY results on Wed Feb 10 (Reuters) - ...
Chairman and former boss Brian McNamee has claimed the departing CEO didn’t have the skills to steer the global biotech’s future. The turmoil at the top adds to a horror six months for CSL. In that ...
The ASX 200 closed slightly lower, and the CSL chief executive stepped down abruptly ahead of tomorrow's half-year results. Catch up on the day's events and insights from our business reporters on the ...